Report Overview:
The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
The Global Pharmaceutical Blockchain Market Size was estimated at USD 38.06 million in 2023 and is projected to reach USD 1012.32 million by 2029, exhibiting a CAGR of 72.77% during the forecast period.
This report provides a deep insight into the global Pharmaceutical Blockchain market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Blockchain Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Blockchain market in any manner.
Global Pharmaceutical Blockchain Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Chronicled Inc.
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
IBM Corporation
Medicalchain
Microsoft Corporation
Organizations Mentioned
American Society of Clinical Oncology (ASCO)
Association of Clinical Trials Organizations (ACTO)
Castor EDC
Clinical Supplies Management Holdings, Inc.
ClinicalTrials.gov
Medpace
N-SIDE
Quanticate
Society for Clinical Trials
Market Segmentation (by Type)
Public
Private
Market Segmentation (by Application)
Supply Chian Management
Clinical Data Exchange and Interoperability
Drug Development
Clinical Trials
Internet of Medical Things (IOMT)& Cyber Security
Other Applications
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Pharmaceutical Blockchain Market
? Overview of the regional outlook of the Pharmaceutical Blockchain Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Blockchain Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical Blockchain
1.2 Key Market Segments
1.2.1 Pharmaceutical Blockchain Segment by Type
1.2.2 Pharmaceutical Blockchain Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical Blockchain Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical Blockchain Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical Blockchain Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical Blockchain Market Competitive Landscape
3.1 Global Pharmaceutical Blockchain Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical Blockchain Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical Blockchain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Blockchain Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical Blockchain Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Blockchain Market Competitive Situation and Trends
3.6.1 Pharmaceutical Blockchain Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical Blockchain Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical Blockchain Industry Chain Analysis
4.1 Pharmaceutical Blockchain Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical Blockchain Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical Blockchain Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Blockchain Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical Blockchain Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical Blockchain Price by Type (2019-2024)
7 Pharmaceutical Blockchain Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Blockchain Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical Blockchain Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical Blockchain Sales Growth Rate by Application (2019-2024)
8 Pharmaceutical Blockchain Market Segmentation by Region
8.1 Global Pharmaceutical Blockchain Sales by Region
8.1.1 Global Pharmaceutical Blockchain Sales by Region
8.1.2 Global Pharmaceutical Blockchain Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical Blockchain Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical Blockchain Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical Blockchain Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical Blockchain Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical Blockchain Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Chronicled Inc.
9.1.1 Chronicled Inc. Pharmaceutical Blockchain Basic Information
9.1.2 Chronicled Inc. Pharmaceutical Blockchain Product Overview
9.1.3 Chronicled Inc. Pharmaceutical Blockchain Product Market Performance
9.1.4 Chronicled Inc. Business Overview
9.1.5 Chronicled Inc. Pharmaceutical Blockchain SWOT Analysis
9.1.6 Chronicled Inc. Recent Developments
9.2 Doc.AI
9.2.1 Doc.AI Pharmaceutical Blockchain Basic Information
9.2.2 Doc.AI Pharmaceutical Blockchain Product Overview
9.2.3 Doc.AI Pharmaceutical Blockchain Product Market Performance
9.2.4 Doc.AI Business Overview
9.2.5 Doc.AI Pharmaceutical Blockchain SWOT Analysis
9.2.6 Doc.AI Recent Developments
9.3 Embleema
9.3.1 Embleema Pharmaceutical Blockchain Basic Information
9.3.2 Embleema Pharmaceutical Blockchain Product Overview
9.3.3 Embleema Pharmaceutical Blockchain Product Market Performance
9.3.4 Embleema Pharmaceutical Blockchain SWOT Analysis
9.3.5 Embleema Business Overview
9.3.6 Embleema Recent Developments
9.4 Factom Inc.
9.4.1 Factom Inc. Pharmaceutical Blockchain Basic Information
9.4.2 Factom Inc. Pharmaceutical Blockchain Product Overview
9.4.3 Factom Inc. Pharmaceutical Blockchain Product Market Performance
9.4.4 Factom Inc. Business Overview
9.4.5 Factom Inc. Recent Developments
9.5 FarmaTrust
9.5.1 FarmaTrust Pharmaceutical Blockchain Basic Information
9.5.2 FarmaTrust Pharmaceutical Blockchain Product Overview
9.5.3 FarmaTrust Pharmaceutical Blockchain Product Market Performance
9.5.4 FarmaTrust Business Overview
9.5.5 FarmaTrust Recent Developments
9.6 Guardtime Federal
9.6.1 Guardtime Federal Pharmaceutical Blockchain Basic Information
9.6.2 Guardtime Federal Pharmaceutical Blockchain Product Overview
9.6.3 Guardtime Federal Pharmaceutical Blockchain Product Market Performance
9.6.4 Guardtime Federal Business Overview
9.6.5 Guardtime Federal Recent Developments
9.7 Hashed Health
9.7.1 Hashed Health Pharmaceutical Blockchain Basic Information
9.7.2 Hashed Health Pharmaceutical Blockchain Product Overview
9.7.3 Hashed Health Pharmaceutical Blockchain Product Market Performance
9.7.4 Hashed Health Business Overview
9.7.5 Hashed Health Recent Developments
9.8 IBM Corporation
9.8.1 IBM Corporation Pharmaceutical Blockchain Basic Information
9.8.2 IBM Corporation Pharmaceutical Blockchain Product Overview
9.8.3 IBM Corporation Pharmaceutical Blockchain Product Market Performance
9.8.4 IBM Corporation Business Overview
9.8.5 IBM Corporation Recent Developments
9.9 Medicalchain
9.9.1 Medicalchain Pharmaceutical Blockchain Basic Information
9.9.2 Medicalchain Pharmaceutical Blockchain Product Overview
9.9.3 Medicalchain Pharmaceutical Blockchain Product Market Performance
9.9.4 Medicalchain Business Overview
9.9.5 Medicalchain Recent Developments
9.10 Microsoft Corporation
9.10.1 Microsoft Corporation Pharmaceutical Blockchain Basic Information
9.10.2 Microsoft Corporation Pharmaceutical Blockchain Product Overview
9.10.3 Microsoft Corporation Pharmaceutical Blockchain Product Market Performance
9.10.4 Microsoft Corporation Business Overview
9.10.5 Microsoft Corporation Recent Developments
9.11 Organizations Mentioned
9.11.1 Organizations Mentioned Pharmaceutical Blockchain Basic Information
9.11.2 Organizations Mentioned Pharmaceutical Blockchain Product Overview
9.11.3 Organizations Mentioned Pharmaceutical Blockchain Product Market Performance
9.11.4 Organizations Mentioned Business Overview
9.11.5 Organizations Mentioned Recent Developments
9.12 American Society of Clinical Oncology (ASCO)
9.12.1 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Basic Information
9.12.2 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product Overview
9.12.3 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product Market Performance
9.12.4 American Society of Clinical Oncology (ASCO) Business Overview
9.12.5 American Society of Clinical Oncology (ASCO) Recent Developments
9.13 Association of Clinical Trials Organizations (ACTO)
9.13.1 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Basic Information
9.13.2 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product Overview
9.13.3 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product Market Performance
9.13.4 Association of Clinical Trials Organizations (ACTO) Business Overview
9.13.5 Association of Clinical Trials Organizations (ACTO) Recent Developments
9.14 Castor EDC
9.14.1 Castor EDC Pharmaceutical Blockchain Basic Information
9.14.2 Castor EDC Pharmaceutical Blockchain Product Overview
9.14.3 Castor EDC Pharmaceutical Blockchain Product Market Performance
9.14.4 Castor EDC Business Overview
9.14.5 Castor EDC Recent Developments
9.15 Clinical Supplies Management Holdings, Inc.
9.15.1 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Basic Information
9.15.2 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product Overview
9.15.3 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product Market Performance
9.15.4 Clinical Supplies Management Holdings, Inc. Business Overview
9.15.5 Clinical Supplies Management Holdings, Inc. Recent Developments
9.16 ClinicalTrials.gov
9.16.1 ClinicalTrials.gov Pharmaceutical Blockchain Basic Information
9.16.2 ClinicalTrials.gov Pharmaceutical Blockchain Product Overview
9.16.3 ClinicalTrials.gov Pharmaceutical Blockchain Product Market Performance
9.16.4 ClinicalTrials.gov Business Overview
9.16.5 ClinicalTrials.gov Recent Developments
9.17 Medpace
9.17.1 Medpace Pharmaceutical Blockchain Basic Information
9.17.2 Medpace Pharmaceutical Blockchain Product Overview
9.17.3 Medpace Pharmaceutical Blockchain Product Market Performance
9.17.4 Medpace Business Overview
9.17.5 Medpace Recent Developments
9.18 N-SIDE
9.18.1 N-SIDE Pharmaceutical Blockchain Basic Information
9.18.2 N-SIDE Pharmaceutical Blockchain Product Overview
9.18.3 N-SIDE Pharmaceutical Blockchain Product Market Performance
9.18.4 N-SIDE Business Overview
9.18.5 N-SIDE Recent Developments
9.19 Quanticate
9.19.1 Quanticate Pharmaceutical Blockchain Basic Information
9.19.2 Quanticate Pharmaceutical Blockchain Product Overview
9.19.3 Quanticate Pharmaceutical Blockchain Product Market Performance
9.19.4 Quanticate Business Overview
9.19.5 Quanticate Recent Developments
9.20 Society for Clinical Trials
9.20.1 Society for Clinical Trials Pharmaceutical Blockchain Basic Information
9.20.2 Society for Clinical Trials Pharmaceutical Blockchain Product Overview
9.20.3 Society for Clinical Trials Pharmaceutical Blockchain Product Market Performance
9.20.4 Society for Clinical Trials Business Overview
9.20.5 Society for Clinical Trials Recent Developments
10 Pharmaceutical Blockchain Market Forecast by Region
10.1 Global Pharmaceutical Blockchain Market Size Forecast
10.2 Global Pharmaceutical Blockchain Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical Blockchain Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical Blockchain Market Size Forecast by Region
10.2.4 South America Pharmaceutical Blockchain Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Blockchain by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmaceutical Blockchain Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical Blockchain by Type (2025-2030)
11.1.2 Global Pharmaceutical Blockchain Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical Blockchain by Type (2025-2030)
11.2 Global Pharmaceutical Blockchain Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical Blockchain Sales (K Units) Forecast by Application
11.2.2 Global Pharmaceutical Blockchain Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical Blockchain Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical Blockchain Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical Blockchain Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmaceutical Blockchain Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmaceutical Blockchain Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Blockchain as of 2022)
Table 10. Global Market Pharmaceutical Blockchain Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmaceutical Blockchain Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical Blockchain Product Type
Table 13. Global Pharmaceutical Blockchain Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical Blockchain
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical Blockchain Market Challenges
Table 22. Global Pharmaceutical Blockchain Sales by Type (K Units)
Table 23. Global Pharmaceutical Blockchain Market Size by Type (M USD)
Table 24. Global Pharmaceutical Blockchain Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmaceutical Blockchain Sales Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical Blockchain Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmaceutical Blockchain Market Size Share by Type (2019-2024)
Table 28. Global Pharmaceutical Blockchain Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmaceutical Blockchain Sales (K Units) by Application
Table 30. Global Pharmaceutical Blockchain Market Size by Application
Table 31. Global Pharmaceutical Blockchain Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmaceutical Blockchain Sales Market Share by Application (2019-2024)
Table 33. Global Pharmaceutical Blockchain Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmaceutical Blockchain Market Share by Application (2019-2024)
Table 35. Global Pharmaceutical Blockchain Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmaceutical Blockchain Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmaceutical Blockchain Sales Market Share by Region (2019-2024)
Table 38. North America Pharmaceutical Blockchain Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmaceutical Blockchain Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmaceutical Blockchain Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmaceutical Blockchain Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmaceutical Blockchain Sales by Region (2019-2024) & (K Units)
Table 43. Chronicled Inc. Pharmaceutical Blockchain Basic Information
Table 44. Chronicled Inc. Pharmaceutical Blockchain Product Overview
Table 45. Chronicled Inc. Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Chronicled Inc. Business Overview
Table 47. Chronicled Inc. Pharmaceutical Blockchain SWOT Analysis
Table 48. Chronicled Inc. Recent Developments
Table 49. Doc.AI Pharmaceutical Blockchain Basic Information
Table 50. Doc.AI Pharmaceutical Blockchain Product Overview
Table 51. Doc.AI Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Doc.AI Business Overview
Table 53. Doc.AI Pharmaceutical Blockchain SWOT Analysis
Table 54. Doc.AI Recent Developments
Table 55. Embleema Pharmaceutical Blockchain Basic Information
Table 56. Embleema Pharmaceutical Blockchain Product Overview
Table 57. Embleema Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Embleema Pharmaceutical Blockchain SWOT Analysis
Table 59. Embleema Business Overview
Table 60. Embleema Recent Developments
Table 61. Factom Inc. Pharmaceutical Blockchain Basic Information
Table 62. Factom Inc. Pharmaceutical Blockchain Product Overview
Table 63. Factom Inc. Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Factom Inc. Business Overview
Table 65. Factom Inc. Recent Developments
Table 66. FarmaTrust Pharmaceutical Blockchain Basic Information
Table 67. FarmaTrust Pharmaceutical Blockchain Product Overview
Table 68. FarmaTrust Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. FarmaTrust Business Overview
Table 70. FarmaTrust Recent Developments
Table 71. Guardtime Federal Pharmaceutical Blockchain Basic Information
Table 72. Guardtime Federal Pharmaceutical Blockchain Product Overview
Table 73. Guardtime Federal Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Guardtime Federal Business Overview
Table 75. Guardtime Federal Recent Developments
Table 76. Hashed Health Pharmaceutical Blockchain Basic Information
Table 77. Hashed Health Pharmaceutical Blockchain Product Overview
Table 78. Hashed Health Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Hashed Health Business Overview
Table 80. Hashed Health Recent Developments
Table 81. IBM Corporation Pharmaceutical Blockchain Basic Information
Table 82. IBM Corporation Pharmaceutical Blockchain Product Overview
Table 83. IBM Corporation Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. IBM Corporation Business Overview
Table 85. IBM Corporation Recent Developments
Table 86. Medicalchain Pharmaceutical Blockchain Basic Information
Table 87. Medicalchain Pharmaceutical Blockchain Product Overview
Table 88. Medicalchain Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Medicalchain Business Overview
Table 90. Medicalchain Recent Developments
Table 91. Microsoft Corporation Pharmaceutical Blockchain Basic Information
Table 92. Microsoft Corporation Pharmaceutical Blockchain Product Overview
Table 93. Microsoft Corporation Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Microsoft Corporation Business Overview
Table 95. Microsoft Corporation Recent Developments
Table 96. Organizations Mentioned Pharmaceutical Blockchain Basic Information
Table 97. Organizations Mentioned Pharmaceutical Blockchain Product Overview
Table 98. Organizations Mentioned Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Organizations Mentioned Business Overview
Table 100. Organizations Mentioned Recent Developments
Table 101. American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Basic Information
Table 102. American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product Overview
Table 103. American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. American Society of Clinical Oncology (ASCO) Business Overview
Table 105. American Society of Clinical Oncology (ASCO) Recent Developments
Table 106. Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Basic Information
Table 107. Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product Overview
Table 108. Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Association of Clinical Trials Organizations (ACTO) Business Overview
Table 110. Association of Clinical Trials Organizations (ACTO) Recent Developments
Table 111. Castor EDC Pharmaceutical Blockchain Basic Information
Table 112. Castor EDC Pharmaceutical Blockchain Product Overview
Table 113. Castor EDC Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Castor EDC Business Overview
Table 115. Castor EDC Recent Developments
Table 116. Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Basic Information
Table 117. Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product Overview
Table 118. Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Clinical Supplies Management Holdings, Inc. Business Overview
Table 120. Clinical Supplies Management Holdings, Inc. Recent Developments
Table 121. ClinicalTrials.gov Pharmaceutical Blockchain Basic Information
Table 122. ClinicalTrials.gov Pharmaceutical Blockchain Product Overview
Table 123. ClinicalTrials.gov Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. ClinicalTrials.gov Business Overview
Table 125. ClinicalTrials.gov Recent Developments
Table 126. Medpace Pharmaceutical Blockchain Basic Information
Table 127. Medpace Pharmaceutical Blockchain Product Overview
Table 128. Medpace Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Medpace Business Overview
Table 130. Medpace Recent Developments
Table 131. N-SIDE Pharmaceutical Blockchain Basic Information
Table 132. N-SIDE Pharmaceutical Blockchain Product Overview
Table 133. N-SIDE Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. N-SIDE Business Overview
Table 135. N-SIDE Recent Developments
Table 136. Quanticate Pharmaceutical Blockchain Basic Information
Table 137. Quanticate Pharmaceutical Blockchain Product Overview
Table 138. Quanticate Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Quanticate Business Overview
Table 140. Quanticate Recent Developments
Table 141. Society for Clinical Trials Pharmaceutical Blockchain Basic Information
Table 142. Society for Clinical Trials Pharmaceutical Blockchain Product Overview
Table 143. Society for Clinical Trials Pharmaceutical Blockchain Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Society for Clinical Trials Business Overview
Table 145. Society for Clinical Trials Recent Developments
Table 146. Global Pharmaceutical Blockchain Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Pharmaceutical Blockchain Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Pharmaceutical Blockchain Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Pharmaceutical Blockchain Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Pharmaceutical Blockchain Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Pharmaceutical Blockchain Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Pharmaceutical Blockchain Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Pharmaceutical Blockchain Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Pharmaceutical Blockchain Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Pharmaceutical Blockchain Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Pharmaceutical Blockchain Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Pharmaceutical Blockchain Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Pharmaceutical Blockchain Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Pharmaceutical Blockchain Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Pharmaceutical Blockchain Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Pharmaceutical Blockchain Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Pharmaceutical Blockchain Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pharmaceutical Blockchain
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical Blockchain Market Size (M USD), 2019-2030
Figure 5. Global Pharmaceutical Blockchain Market Size (M USD) (2019-2030)
Figure 6. Global Pharmaceutical Blockchain Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical Blockchain Market Size by Country (M USD)
Figure 11. Pharmaceutical Blockchain Sales Share by Manufacturers in 2023
Figure 12. Global Pharmaceutical Blockchain Revenue Share by Manufacturers in 2023
Figure 13. Pharmaceutical Blockchain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmaceutical Blockchain Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Blockchain Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical Blockchain Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical Blockchain by Type (2019-2024)
Figure 19. Sales Market Share of Pharmaceutical Blockchain by Type in 2023
Figure 20. Market Size Share of Pharmaceutical Blockchain by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmaceutical Blockchain by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical Blockchain Market Share by Application
Figure 24. Global Pharmaceutical Blockchain Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmaceutical Blockchain Sales Market Share by Application in 2023
Figure 26. Global Pharmaceutical Blockchain Market Share by Application (2019-2024)
Figure 27. Global Pharmaceutical Blockchain Market Share by Application in 2023
Figure 28. Global Pharmaceutical Blockchain Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmaceutical Blockchain Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmaceutical Blockchain Sales Market Share by Country in 2023
Figure 32. U.S. Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmaceutical Blockchain Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmaceutical Blockchain Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmaceutical Blockchain Sales Market Share by Country in 2023
Figure 37. Germany Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmaceutical Blockchain Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmaceutical Blockchain Sales Market Share by Region in 2023
Figure 44. China Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmaceutical Blockchain Sales and Growth Rate (K Units)
Figure 50. South America Pharmaceutical Blockchain Sales Market Share by Country in 2023
Figure 51. Brazil Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmaceutical Blockchain Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmaceutical Blockchain Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmaceutical Blockchain Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmaceutical Blockchain Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmaceutical Blockchain Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmaceutical Blockchain Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmaceutical Blockchain Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmaceutical Blockchain Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmaceutical Blockchain Market Share Forecast by Application (2025-2030)
